ClinVar Miner

Submissions for variant NM_000251.3(MSH2):c.1224T>G (p.Tyr408Ter)

dbSNP: rs63750132
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Ambry Genetics RCV000569136 SCV000676100 pathogenic Hereditary cancer-predisposing syndrome 2019-03-27 criteria provided, single submitter clinical testing The p.Y408* pathogenic mutation (also known as c.1224T>G), located in coding exon 7 of the MSH2 gene, results from a T to G substitution at nucleotide position 1224. This changes the amino acid from a tyrosine to a stop codon within coding exon 7. This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation.
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV000780440 SCV000917689 likely pathogenic Lynch syndrome 2018-02-20 criteria provided, single submitter clinical testing Variant summary: MSH2 c.1224T>G (p.Tyr408X) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory (eg. c.1477C>T (p.Gln493X), c.1576delA (p.Thr526fsX17), and c.1705_1706delGA (p.Glu569fsX2)). The variant was absent in 246208 control chromosomes (gnomAD). To our knowledge, no occurrence of c.1224T>G in individuals affected with Lynch Syndrome and no experimental evidence demonstrating its impact on protein function have been reported. A ClinVar submission from a clinical diagnostic laboratory (evaluation after 2014) classifies the variant as pathogenic. Based on the evidence outlined above, the variant was classified as likely pathogenic.
Myriad Genetics, Inc. RCV003451284 SCV004188982 pathogenic Lynch syndrome 1 2023-08-01 criteria provided, single submitter clinical testing This variant is considered pathogenic. This variant creates a termination codon and is predicted to result in premature protein truncation.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.